WHA Logo

Are you sure you want to leave?

You are about to leave our site and access an external link. The content of the site you will visit is not under our control. Do you wish to continue?

Alvogen - Fentanyl transdermal system 25 mcg/h 

Alvogen announced a voluntary, consumer level recall of one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches because there is a potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch.

 

Classification Type: Class 1 Recall

Optum Clinical Services has sent a drug recall notification to potentially impacted members and providers.

 

Below are the notification details.